IH
IH
iHuman Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $204.69M ▲ | $123.31M ▲ | $21.47M ▼ | 10.49% ▼ | $2.1 ▼ | $16.58M ▼ |
| Q2-2025 | $200.16M ▼ | $116.26M ▼ | $31.89M ▲ | 15.93% ▲ | $3.1 ▲ | $19.49M ▼ |
| Q1-2025 | $210.44M ▼ | $122.18M ▼ | $26.52M ▲ | 12.6% ▲ | $2.55 | $21.6M ▲ |
| Q4-2024 | $232.68M ▼ | $141.52M ▼ | $26.48M ▲ | 11.38% ▲ | $2.55 ▲ | $14.92M ▼ |
| Q3-2024 | $239.41M | $143.17M | $25.14M | 10.5% | $2.4 | $20.7M |
What's going well?
Revenue and gross profit are both up, showing the company is still growing. Margins remain high, and there is no debt burden. The business is still profitable overall.
What's concerning?
Operating expenses are rising much faster than sales, squeezing profits. Net income and earnings per share dropped sharply, and efficiency is slipping. If costs keep rising, future profits could be at risk.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.13B ▲ | $1.37B ▲ | $384.8M ▲ | $983.48M ▲ |
| Q2-2025 | $1.1B ▼ | $1.34B ▼ | $365.7M ▼ | $969.39M ▲ |
| Q1-2025 | $1.12B ▼ | $1.37B ▼ | $431.15M ▼ | $941.04M ▼ |
| Q4-2024 | $1.17B ▲ | $1.42B ▼ | $458.8M ▼ | $960.85M ▲ |
| Q3-2024 | $1.17B | $1.42B | $494.31M | $926.33M |
What's financially strong about this company?
IH has over $1.1 billion in cash and investments, very little debt, and more than enough assets to cover all liabilities. The company is growing its equity and buying back shares, showing confidence in its future.
What are the financial risks or weaknesses?
Receivables and payables are both rising, which could signal slower customer payments or delayed supplier payments. Deferred revenue dipped, so watch for any slowdown in customer prepayments.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $31.89M ▲ | $0 | $0 | $0 | $0 | $0 |
| Q1-2025 | $26.52M ▲ | $0 | $0 | $0 | $0 | $0 |
| Q4-2024 | $26.48M ▲ | $0 | $0 | $0 | $0 | $0 |
| Q3-2024 | $25.14M ▲ | $0 | $0 | $0 | $0 | $0 |
| Q2-2024 | $24.66M | $0 | $0 | $0 | $0 | $0 |
Q1 2021 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at iHuman Inc.'s financial evolution and strategic trajectory over the past five years.
Core strengths include a robust, cash-rich balance sheet with minimal debt, consistently high gross margins that reflect attractive economics, and a proven ability to move from losses to solid profitability. On the strategic side, iHuman benefits from a differentiated AI-driven product ecosystem, strong brand associations in early-childhood education, diversified revenue channels across consumers and institutions, and deep partnerships that enhance both content quality and distribution reach.
Key risks center on the recent deterioration in financial momentum and the challenging industry environment. Revenue and profits have stepped down from their peaks, and operating and free cash flow have weakened sharply, suggesting more fragile underlying performance than earlier years implied. The restart of dividends against this backdrop may constrain flexibility if cash flows do not recover. In addition, regulatory risk in education, intense competition, and execution challenges in overseas expansion and older age segments all add uncertainty.
Looking ahead, iHuman appears financially secure and strategically well-positioned, but with a more mixed near-term performance profile. The company has the resources and technological capabilities to pursue growth and deepen its competitive moat, yet it must demonstrate that it can re-stabilize growth, protect margins, and rebuild stronger, more consistent cash generation. The trajectory of international initiatives, user engagement across age groups, and the balance between innovation spending and profitability will largely shape its medium-term prospects.
About iHuman Inc.
https://www.ihuman.comiHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $204.69M ▲ | $123.31M ▲ | $21.47M ▼ | 10.49% ▼ | $2.1 ▼ | $16.58M ▼ |
| Q2-2025 | $200.16M ▼ | $116.26M ▼ | $31.89M ▲ | 15.93% ▲ | $3.1 ▲ | $19.49M ▼ |
| Q1-2025 | $210.44M ▼ | $122.18M ▼ | $26.52M ▲ | 12.6% ▲ | $2.55 | $21.6M ▲ |
| Q4-2024 | $232.68M ▼ | $141.52M ▼ | $26.48M ▲ | 11.38% ▲ | $2.55 ▲ | $14.92M ▼ |
| Q3-2024 | $239.41M | $143.17M | $25.14M | 10.5% | $2.4 | $20.7M |
What's going well?
Revenue and gross profit are both up, showing the company is still growing. Margins remain high, and there is no debt burden. The business is still profitable overall.
What's concerning?
Operating expenses are rising much faster than sales, squeezing profits. Net income and earnings per share dropped sharply, and efficiency is slipping. If costs keep rising, future profits could be at risk.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.13B ▲ | $1.37B ▲ | $384.8M ▲ | $983.48M ▲ |
| Q2-2025 | $1.1B ▼ | $1.34B ▼ | $365.7M ▼ | $969.39M ▲ |
| Q1-2025 | $1.12B ▼ | $1.37B ▼ | $431.15M ▼ | $941.04M ▼ |
| Q4-2024 | $1.17B ▲ | $1.42B ▼ | $458.8M ▼ | $960.85M ▲ |
| Q3-2024 | $1.17B | $1.42B | $494.31M | $926.33M |
What's financially strong about this company?
IH has over $1.1 billion in cash and investments, very little debt, and more than enough assets to cover all liabilities. The company is growing its equity and buying back shares, showing confidence in its future.
What are the financial risks or weaknesses?
Receivables and payables are both rising, which could signal slower customer payments or delayed supplier payments. Deferred revenue dipped, so watch for any slowdown in customer prepayments.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $31.89M ▲ | $0 | $0 | $0 | $0 | $0 |
| Q1-2025 | $26.52M ▲ | $0 | $0 | $0 | $0 | $0 |
| Q4-2024 | $26.48M ▲ | $0 | $0 | $0 | $0 | $0 |
| Q3-2024 | $25.14M ▲ | $0 | $0 | $0 | $0 | $0 |
| Q2-2024 | $24.66M | $0 | $0 | $0 | $0 | $0 |
Q1 2021 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at iHuman Inc.'s financial evolution and strategic trajectory over the past five years.
Core strengths include a robust, cash-rich balance sheet with minimal debt, consistently high gross margins that reflect attractive economics, and a proven ability to move from losses to solid profitability. On the strategic side, iHuman benefits from a differentiated AI-driven product ecosystem, strong brand associations in early-childhood education, diversified revenue channels across consumers and institutions, and deep partnerships that enhance both content quality and distribution reach.
Key risks center on the recent deterioration in financial momentum and the challenging industry environment. Revenue and profits have stepped down from their peaks, and operating and free cash flow have weakened sharply, suggesting more fragile underlying performance than earlier years implied. The restart of dividends against this backdrop may constrain flexibility if cash flows do not recover. In addition, regulatory risk in education, intense competition, and execution challenges in overseas expansion and older age segments all add uncertainty.
Looking ahead, iHuman appears financially secure and strategically well-positioned, but with a more mixed near-term performance profile. The company has the resources and technological capabilities to pursue growth and deepen its competitive moat, yet it must demonstrate that it can re-stabilize growth, protect margins, and rebuild stronger, more consistent cash generation. The trajectory of international initiatives, user engagement across age groups, and the balance between innovation spending and profitability will largely shape its medium-term prospects.

CEO
Peng Dai
Compensation Summary
(Year )
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 43
Ratings Snapshot
Rating : A-

